Respiratory Testing Enters a Period of Recalibration
As pandemic-era practices give way to more tailored strategies, laboratories are reconsidering how much respiratory testing is appropriate for different patients and clinical situations.
Read MorePosted by CLP Edit Staff | Sep 10, 2026 | Flu & Respiratory Infections |
As pandemic-era practices give way to more tailored strategies, laboratories are reconsidering how much respiratory testing is appropriate for different patients and clinical situations.
Read MorePosted by CLP Edit Staff | Sep 9, 2026 | Cancer, Molecular Diagnostics |
Yourgene Health has launched its IVDR-certified DPYD assay in Europe, enabling detection of 19 DPYD gene variants to help clinical labs identify cancer patients at risk of severe toxicity from fluoropyrimidine chemotherapy.
Read MorePosted by CLP Edit Staff | Sep 8, 2026 | Company News |
Labcorp has acquired MLM Medical Labs, expanding its central laboratory network to four continents and strengthening biomarker and specialty testing capabilities for clinical trials, according to a company announcement.
Read MorePosted by CLP Edit Staff | Sep 8, 2026 | Amplification Technologies |
Anitoa Systems has added cloud connectivity and enterprise-grade security to its portable qPCR instruments, enabling remote management, centralized data collection, and real-time biosurveillance, according to the company.
Read MorePosted by CLP Edit Staff | Sep 3, 2026 | Gastrointestinal Infections |
A University of Washington study found the panel cross-reacts with 78 gut bacteria species, resulting in over 250,000 false-positive norovirus results since 2019.
Read More